middle.news
CSL taps ViiV chief Deborah Waterhouse to lead its next growth chapter
4:37pm on Wednesday 21st of October, 2026 AEDT
•
Healthcare
Read Story
CSL taps ViiV chief Deborah Waterhouse to lead its next growth chapter
4:37pm on Wednesday 21st of October, 2026 AEDT
Key Points
Deborah Waterhouse appointed CEO and managing director from 1 February 2027
Current ViiV Healthcare CEO with more than 25 years in global specialty pharmaceuticals
Gordon Naylor to remain interim CEO before returning to CSL’s board
£1.5 million base salary plus performance incentives and GSK buyout awards
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
CSL (ASX:CSL)
OPEN ARTICLE